首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.
【24h】

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

机译:抑郁症妇女血清中脑源性神经营养因子(BDNF)的变化。

获取原文
获取原文并翻译 | 示例
           

摘要

Neuroplastic processes are thought to be involved in the pathophysiology of many psychiatric disorders, including major depression. It has been hypothesized that the brain-derived neurotrophic factor (BNDF), a key factor in neuroplasticity, is associated with depressive disorders. Our study evaluated the pre- and post-treatment levels of BDNF in a group of depressed patients and compared them with healthy controls. In order to exclude the effects of gender on neuroplasticity, our study group was restricted to women exclusively and consisted of 20 depressive patients and 20 healthy controls, with similar age and educational level distribution. Blood samples were collected before the treatment and on the sixth week of the treatment with 10 mg S-citalopram. The pre-treatment BDNF levels of the depressed patients were found to be lower than those of the healthy subjects. During the sixth week, the BDNF levels of depressive patients were significantly higher than the pre-treatment levels but similar to those of control subjects. These findings suggest that BDNF level may be an important factor in the etiopathogenesis of depression and may have a role in the action mechanism of antidepressant drugs.
机译:神经塑性过程被认为与许多精神疾病,包括重度抑郁症的病理生理有关。据推测,脑可塑性的关键因素脑源性神经营养因子(BNDF)与抑郁症有关。我们的研究评估了一组抑郁症患者治疗前后的BDNF水平,并将其与健康对照组进行了比较。为了排除性别对神经可塑性的影响,我们的研究组仅限于女性,由20名抑郁症患者和20名健康对照组组成,年龄和文化程度分布相似。在治疗之前和治疗的第六周,用10mg S-西酞普兰收集血样。发现抑郁症患者的治疗前BDNF水平低于健康受试者。在第六周,抑郁症患者的BDNF水平显着高于治疗前水平,但与对照组相似。这些发现表明BDNF水平可能是抑郁症的发病机制中的重要因素,并且可能在抗抑郁药的作用机制中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号